Volition Rx

VolitionRx is a life sciences company focused on developing blood-based diagnostic tests for different types of cancer. The tests are based on the science of Nucleosomics which is the practice of identifying and measuring nucleosomes in the bloodstream – an indication that cancer is present. VolitionRx's goal is to make the tests as common and simple to use, for both patients and doctors, as existing diabetic and cholesterol blood tests. VolitionRx's research and development activities are currently centered in Belgium as the company focuses on bringing its diagnostic products to market first in Europe, then in the US and ultimately, worldwide.

Find a broker to begin trading VNRX now

Company Name Volition Rx
Market/Symbol NYSE MKT: VNRX
Recent Price
Market Cap $92.79M
Avg. Daily Vol. (3m) 26,824
Price/Book N/A
Price/Cash Flow 15x
As of May. 26, 2017
*Source: QuoteMedia

Begin trading VNRX

 Find Broker

Recent Company Videos

Volition Rx, Ltd. (OTC QB: VNRX)

Dec. 19, 2014

RedChip Research Director, Thomas Pfister, CFA, interviews Cameron Reynolds, CEO of Volition Rx (OTCQB: VNRX), a life sciences company focused on ...

Volition Rx Latest News

Ask the CEO

Want more information? View our latest virtual conference.

Receive VNRX Email Alerts

*By entering your information you agree to our privacy policy.

"I work with many of the companies that would be RedChip companies. And we certainly ascribe to the same view that the RedChip Companies do, which is Discovering Tomorrow's Blue Chips Today."

  • Bob McCooey, Senior Vice President The NASDAQ Stock Market